Pyxis Accounts Payable from 2010 to 2024

PYXS Stock  USD 1.89  0.01  0.53%   
Pyxis Oncology Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable is likely to outpace its year average in 2024. Accounts Payable is the amount Pyxis Oncology owes to suppliers or vendors for products or services received but not yet paid for. It represents Pyxis Oncology's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
3.9 M
Current Value
5.4 M
Quarterly Volatility
3.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pyxis Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pyxis Oncology's main balance sheet or income statement drivers, such as Net Interest Income of 7.3 M, Interest Income of 7.3 M or Depreciation And Amortization of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.6. Pyxis financial statements analysis is a perfect complement when working with Pyxis Oncology Valuation or Volatility modules.
  
Check out the analysis of Pyxis Oncology Correlation against competitors.
For more information on how to buy Pyxis Stock please use our How to Invest in Pyxis Oncology guide.

Latest Pyxis Oncology's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Pyxis Oncology over the last few years. An accounting item on the balance sheet that represents Pyxis Oncology obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Pyxis Oncology are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Pyxis Oncology's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pyxis Oncology's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Pyxis Accounts Payable Regression Statistics

Arithmetic Mean2,288,243
Geometric Mean1,030,217
Coefficient Of Variation148.88
Mean Deviation2,557,823
Median491,000
Standard Deviation3,406,749
Sample Variance11.6T
Range11.5M
R-Value0.63
Mean Square Error7.5T
R-Squared0.40
Significance0.01
Slope483,462
Total Sum of Squares162.5T

Pyxis Accounts Payable History

20245.4 M
20233.9 M
20227.1 M
202112 M
20201.1 M

About Pyxis Oncology Financial Statements

Pyxis Oncology shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Pyxis Oncology investors may analyze each financial statement separately, they are all interrelated. The changes in Pyxis Oncology's assets and liabilities, for example, are also reflected in the revenues and expenses on on Pyxis Oncology's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable3.9 M5.4 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pyxis Stock Analysis

When running Pyxis Oncology's price analysis, check to measure Pyxis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pyxis Oncology is operating at the current time. Most of Pyxis Oncology's value examination focuses on studying past and present price action to predict the probability of Pyxis Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pyxis Oncology's price. Additionally, you may evaluate how the addition of Pyxis Oncology to your portfolios can decrease your overall portfolio volatility.